TBI-166,98.00%
产品编号:Bellancom-148564| CAS NO:1353734-12-9| 分子式:C32H30F3N5O3| 分子量:589.61
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
TBI-166
产品介绍 | TBI-166,一种利米吩嗪类似物,是一种具有口服活性的抗结核活性分子,不良反应比 riminophenazine 化合物 Clofazimine (HY-B1046) 小。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | TBI-166, a riminophenazine analogue, is an orally active anti-tuberculosis agent with fewer adverse reactions than the lead riminophenazine compound, Clofazimine (HY-B1046) . | ||||||||||||||||
体外研究 |
TBI-166 抑制 M. tuberculosis H37Rv 复制 (MIC: 0.063 μg/mL),对 16 种药物敏感的临床分离株 (分枝杆菌属) 也有效,MIC 为 0.005-0.15μg/mL。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
TBI-166 (10-80 mg/kg,口服,8 周) 在慢性小鼠 M. tuberculosis H37Rv 感染模型中表现出抗结核活性。 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
体内研究 |
TBI-166 (10-80 mg/kg,口服,8 周) 在慢性小鼠 M. tuberculosis H37Rv 感染模型中表现出抗结核活性。 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 9.09 mg/mL (15.42 mM; ultrasonic and adjust pH to 3 with HCl) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
参考文献 |
|